Tower Research Capital (TRC)’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $757 | Buy |
+14
| New | +$780 | ﹤0.01% | 4785 |
|
|
2025
Q4 | – | Sell |
-2
| Closed | -$96 | – | 5664 |
|
|
2025
Q3 | $96 | Sell |
2
-4
| -67% | -$179 | ﹤0.01% | 5112 |
|
|
2025
Q2 | $243 | Sell |
6
-125
| -95% | -$5.03K | ﹤0.01% | 5087 |
|
|
2025
Q1 | $5.74K | Buy |
131
+122
| +1,356% | +$5.38K | ﹤0.01% | 4088 |
|
|
2024
Q4 | $387 | Buy |
9
+6
| +200% | +$273 | ﹤0.01% | 5299 |
|
|
2024
Q3 | $133 | Sell |
3
-2
| -40% | -$86 | ﹤0.01% | 5477 |
|
|
2024
Q2 | $199 | Sell |
5
-11
| -69% | -$446 | ﹤0.01% | 5406 |
|
|
2024
Q1 | $690 | Sell |
16
-225
| -93% | -$9.7K | ﹤0.01% | 5410 |
|
|
2023
Q4 | $10K | Buy |
241
+235
| +3,917% | +$8.9K | ﹤0.01% | 4308 |
|
|
2023
Q3 | $238 | Buy |
+6
| New | +$254 | ﹤0.01% | 5641 |
|
|
2023
Q2 | – | Sell |
-19
| Closed | -$1K | – | 6397 |
|
|
2023
Q1 | $1K | Buy |
+19
| New | +$798 | ﹤0.01% | 5633 |
|
|
2022
Q4 | – | Sell |
-7,134
| Closed | -$286K | – | 6450 |
|
|
2022
Q3 | $286K | Sell |
7,134
-4,075
| -36% | -$174K | ﹤0.01% | 1590 |
|
|
2022
Q2 | $471K | Buy |
+11,209
| New | +$470K | 0.01% | 1175 |
|
|
2022
Q1 | – | Sell |
-3,509
| Closed | -$162K | – | 6602 |
|
|
2021
Q4 | $162K | Buy |
3,509
+2,560
| +270% | +$121K | ﹤0.01% | 1923 |
|
|
2021
Q3 | $45K | Buy |
+949
| New | +$47.2K | ﹤0.01% | 3052 |
|
|
2020
Q4 | – | Sell |
-11,899
| Closed | -$517K | – | 5449 |
|
|
2020
Q3 | $517K | Buy |
+11,899
| New | +$521K | 0.01% | 1644 |
|
|
2020
Q1 | – | Sell |
-20,957
| Closed | -$957K | – | 4018 |
|
|
2019
Q4 | $957K | Sell |
20,957
-11,834
| -36% | -$469K | 0.08% | 120 |
|
|
2019
Q3 | $1.17M | Buy |
32,791
+22,495
| +218% | +$836K | 0.08% | 237 |
|
|
2019
Q2 | $410K | Sell |
10,296
-7,761
| -43% | -$305K | 0.03% | 558 |
|
|
2019
Q1 | $751K | Sell |
18,057
-19,161
| -51% | -$779K | 0.05% | 391 |
|
|
2018
Q4 | $1.36M | Buy |
37,218
+29,821
| +403% | +$1.27M | 0.1% | 203 |
|
|
2018
Q3 | $359K | Sell |
7,397
-12,136
| -62% | -$575K | 0.03% | 663 |
|
|
2018
Q2 | $840K | Sell |
19,533
-27,237
| -58% | -$1.14M | 0.05% | 404 |
|
|
2018
Q1 | $1.96M | Buy |
46,770
+2,211
| +5% | +$96.3K | 0.17% | 94 |
|
|
2017
Q4 | $1.94M | Buy |
44,559
+44,082
| +9,242% | +$1.87M | 0.25% | 78 |
|
|
2017
Q3 | $20K | Sell |
477
-36,992
| -99% | -$1.57M | ﹤0.01% | 2737 |
|
|
2017
Q2 | $1.61M | Buy |
37,469
+4,469
| +14% | +$188K | 0.18% | 96 |
|
|
2017
Q1 | $1.38M | Buy |
33,000
+2,984
| +10% | +$122K | 0.14% | 61 |
|
|
2016
Q4 | $1.17M | Buy |
+30,016
| New | +$1.22M | 0.13% | 172 |
|
|
2016
Q3 | – | Sell |
-23,580
| Closed | -$986K | – | 4557 |
|
|
2016
Q2 | $986K | Sell |
23,580
-1,997
| -8% | -$84.6K | 0.09% | 158 |
|
|
2016
Q1 | $1.03M | Buy |
25,577
+21,139
| +476% | +$896K | 0.15% | 112 |
|
|
2015
Q4 | $227K | Sell |
4,438
-21,578
| -83% | -$1.1M | 0.04% | 180 |
|
|
2015
Q3 | $1.22M | Sell |
26,016
-23,044
| -47% | -$1.39M | 0.12% | 100 |
|
|
2015
Q2 | $3.06M | Sell |
49,060
-43,538
| -47% | -$2.71M | 0.27% | 42 |
|
|
2015
Q1 | $5.72M | Buy |
92,598
+49,416
| +114% | +$2.93M | 0.71% | 13 |
|
|
2014
Q4 | $2.33M | Buy |
43,182
+19,072
| +79% | +$1.04M | 0.23% | 63 |
|
|
2014
Q3 | $1.28M | Buy |
24,110
+15,260
| +172% | +$776K | 0.14% | 131 |
|
|
2014
Q2 | $459K | Sell |
8,850
-64,070
| -88% | -$3.09M | 0.06% | 291 |
|
|
2014
Q1 | $3.41M | Buy |
72,920
+290
| +0.4% | +$13.7K | 0.44% | 44 |
|
|
2013
Q4 | $3.19M | Buy |
+72,630
| New | +$3.02M | 0.53% | 29 |
|
Other funds holding XPH
KWM
FCBT
